Antioxidant effects of a single dose of acetylsalicylic acid and salicylic acid in rat brain slices subjected to oxygen-glucose deprivation in relation with its antiplatelet effect

Neuroscience Letters

Volumn 358, Issue 3, 2004, Pages 153-156

  Guerrero, A ^a   Gonzalez Correa J A ^a   Arrebola, M M ^a   Munoz Marin J ^a   Sanchez De La Cuesta F ^a   De La Cruz, J P ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Acetylsalicylic acid; Brain anoxia; Oxidative stress; Salicylic acid

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; GLUCOSE; GLUTATHIONE; LACTATE DEHYDROGENASE; OXYGEN; SALICYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BRAIN HYPOXIA; BRAIN LEVEL; BRAIN SLICE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; OXYGEN SUPPLY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALS; ANTIOXIDANTS; ASPIRIN; CELL HYPOXIA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; GLUCOSE; GLUTATHIONE; HYPOXIA-ISCHEMIA, BRAIN; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; SALICYLIC ACID;

EID: 1642307287     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.01.036     Document Type: Article

References (20)

1. Anasuma M., Nishibayashi-Asanuma S., Miyazaki I., Cono M., Ogawa N. Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J. Neurochem. 76:2001;1895-1904.
2. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br. Med. J. 324:2002;71-86.
3. Cardinal D.C., Flower R.J. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J. Pharm. Methods. 3:1980;135-158.
4. De Cristobal J., Cárdenas A., Lizasoain I., Leza J.C., Fernández-Tomé P., Lorenzo P., Moro M.A. Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation. Stroke. 33:2002;261-267.
5. De La Cruz J.P., Carrasco T., Ortega G., SánchezDe La Cuesta F. Inhibition of ferrous-induced lipid peroxidation by pyrimido-pyrimidine derivatives in human liver membranes. Lipids. 27:1992;192-194.
6. De La Cruz J.P., Guerrero A., Paniego M.J., Arranz I., Moreno A., SánchezDe La Cuesta F. Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy. Naunyn-Schmiedeberg's Arch. Pharmacol. 365:2002;96-101.
7. De La Cruz J.P., Villalobos M.A., Cuerda M.A., Guerrero A., González-Correa J.A., SánchezDe La Cuesta F. Effects of S-adenosyl-L-methionine on lipid peroxidation and glutathione levels in rat brain slices exposed to reoxygenation after oxygen-glucose deprivation. Neurosci. Lett. 318:2002;103-107.
8. Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation. Science. 274:1996;1383-1385.
9. Grotta J.C., Lemak N.A., Gary H., Fields W.S., Vital D. Does platelet antiaggregant therapy lessen the severity of stroke? Neurology. 35:1985;632-636.
10. De La Cruz J.P., Guerrero A., Gonzalez-Correa J.A., Arrebola M.M., SanchezDe La Cuesta F. Antioxidant effect of acetylsalicylic acid in rat brain slices subjected to hypoxia. J. Neurosci. Res. 75:2004;280-290.
11. Hissin P.J., Hill R. A fluorimetric method of determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:1976;214-226.
12. Khayyam N., Thavendiranathan P., Carmichael F.J., Kus B., Jay B., Burnham W.M. Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia. NeuroReport. 10:1999;371-374.
13. Kontos H.A. Oxygen radicals in cerebral ischemia: the 2001 Willis Lecture. Stroke. 32:2001;2712-2716.
14. Levy G. Pharmacokinetics of aspirin in man. J. Invest. Dermatol. 67:1976;667-669.
15. Moro M.A., De Alba J., Cárdenas A., De Cristóbal J., Leza J.C., Lizasoain I., Díaz-Guerra M.J.M., Boscá L., Lorenzo P. Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices. Neuropharmacology. 39:2000;1309-1318.
16. Moro M.A., De Alba J., Leza J.C., Lorenzo P., Fernández A.P., Ventura M.L., Boscá L., Rodrigo J., Lizasoain I. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur. J. Neurosci. 10:1998;445-456.
17. Roth G.J., Stanford N., Majerus P.W. Acetylation of prostaglandin synthase by aspirin. Proc. Natl. Acad. Sci. USA. 72:1975;3073-3076.
18. Rumble H.C., Roberts M.S. Determination of aspirin and its major metabolites in plasma by high-performance liquid chromatography without solvent extraction. J. Chromatogr. 225:1981;252-260.
19. Sagone A.L., Husney R.M. Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems. J. Immunol. 138:1987;2177-2183.
20. Venturini L., Sparber S.B. Salicylate and cocaine: interactive toxicity during chicken mid-embryogenesis. Free Radic. Biol. Med. 30:2001;198-207.